Respiratory syncytial virus

Epidemiological Characteristics of RSV

RSV Burden in Jazan

Beyond High-Risk: Expanding RSV Protection for Newborns and Infants

Nirsevimab RWD Metanalysis

Nirsevimab Metanalysis Real world data

Real World Evidence Impact of universal immunization with Nirsevimab

Burden of Disease

RSV History

RSV

All Infant Protection

Nirsevimab : Clinical Experience

RSV Burden in Infants

Nirsevimab International Recommendation

Rattle

Saudi initiatives on Bronchiolitis Recommendations

The first choice of RSV prevention is Nirsevimab; alternatively, palivizumab is to be considered in case of unavailability of Nirsevimab.

Beyfortus®, an innovative immunization

Beyfortus in Action

Beyfortus in Action ECMMID

Implementing Beyfortus successfully

Implementing Beyfortus successfully (US)

Implementing Beyfortus successfully (ES)

Implementing Beyfortus successfully (FR)

2024 RSV International Congress ECMMID

2024 RSV International Congress - ESPID